Latest Breaking News On - Protocol co chair - Page 1 : comparemela.com

Very early treatment of newborns with HIV could result in medication-free remission for many babies

Very early treatment of newborns with HIV could result in medication-free remission for many babies
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

United statesSouth africaJennifer jaoAnn roberth lurieSusanb depreeKellen chadwickInternational maternal pediatric adolescentStanley manne children research instituteProtocol coNational institute of mental healthHuman developmentNational institutes of healthNorthwestern university feinberg school of medicineNational institute of allergyClinical trials networkProtocol co chair

Early treatment offers chance at medication-free remission for pediatric HIV patients

An unexpectedly high percentage of children, who were born with HIV and started treatment within 48 hours of life, exhibit biomarkers by 2 years of age that may make them eligible to test for medication-free remission, according to a multinational study published in Lancet HIV.

United statesSouth africaJennifer jaoKellen chadwickAnn roberth lurieSusanb depreeHuman developmentInternational maternal pediatric adolescentProtocol coNorthwestern university feinberg school of medicineNational institute of allergyStanley manne children research instituteNational institutes of healthClinical trials networkNational institute of mental healthProtocol co chair

Very early treatment of newborns with HIV could result in medication-free remission for many babies

Very early treatment of newborns with HIV could result in medication-free remission for many babies
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.

United statesSouth africaJennifer jaoAnn roberth lurieSusanb depreeKellen chadwickNational institute of mental healthHuman developmentStanley manne children research instituteInternational maternal pediatric adolescentClinical trials networkNational institute of allergyNational institutes of healthProtocol coNorthwestern university feinberg school of medicineProtocol co chair

Women in Health: From test tubes to impacting lives – Dr Thesla Palanee-Phillips on making a difference with science

Dr Thesla-Palanee Phillips' research has made headlines worldwide. She chats to Spotlight about her career, her journey with IVF, and juggling her professional and personal life.

Western capeSouth africaUnited kingdomKwazulu natalEastern capeSouth africanThesla palanee phillipsThesla palaneeJared baetenDaphney concoInstitute witsNelsonr mandela school of medicineUniversity of kwazuluFaculty of health sciencesWits reproductive healthAfrica centre for health

Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard® in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease

T-Guard®, under development by Xenikos B.V., is being studied in comparison to ruxolitinib in patients with Grade III or IV SR-aGHVDCARY, N.C., Ju.

United statesNorth carolinaJohn levineGabrielle meyersUlf meier kriescheAsahi kaseiMehdi hamadaniAshai kaseiMark hensleyNational cancer instituteCore transplant centers consortiaMarrow transplant researchVeloxis pharmaceuticalsInternational bloodOregon healthAsahi kasei group